According to the research report, the global genesynthesis market size is expected to touch USD 10.4 Billion by 2030, from USD 2.1 Billion in 2021, growing with a significant CAGR of 19.45% from 2022 to 2030.
The gene synthesis market report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global gene synthesis market in
conjunction with the geographical landscape of this vertical have also been
included in this report.
The report offers intricate dynamics about
different aspects of the global gene synthesis market, which aids companies operating
in the market in making strategic development decisions. The study also
elaborates on significant changes that are highly anticipated to configure
growth of the global gene synthesis market during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample Link https://www.precedenceresearch.com/sample/2278
| Report Coverage | Details |
| Market Size in 2022 | USD 2.51 Billion |
| Market Size by 2030 | USD 10.4 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 19.45% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Method, Service, Application, End Users, and Geography |
This study covers a detailed segmentation
of the global gene synthesis market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global gene synthesis market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players are OriGene Technologies,Inc, Integrated DNA Technologies, Inc, Thermo Fisher Scientific, Inc, ProMab Biotechnologies, Inc, Eurofins Scientific, Biomatik, ProteoGenix, Bosyer Biological Technology, GenScript, Brooks Automation, Inc (GENEWIZ), Twist Bioscience, Codex DNA
Market Segmentation
- Solid-phase synthesis
- Chip-based synthesis
- PCR- based Enzyme synthesis
By Service
- Antibody DNA synthesis
- Viral DNA synthesis
- Others
By Application
- Gene & cell therapy development
- Vaccine development
- Diseases diagnosis
- Others
By End Users
- Biotechnology & pharmaceutical companies
- Academic & government research institutes
- Contract research organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global gene synthesis market report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global gene synthesis market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Gene Synthesis Market
5.1. COVID-19 Landscape: Gene Synthesis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Gene Synthesis Market, By Method
8.1. Gene Synthesis Market, by Method, 2022-2030
8.1.1. Solid-phase synthesis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Chip- based synthesis
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. PCR- based Enzyme synthesis
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Gene Synthesis Market, By Service
9.1. Gene Synthesis Market, by Service, 2022-2030
9.1.1. Antibody DNA synthesis
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Viral DNA synthesis
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Gene Synthesis Market, By Application
10.1. Gene Synthesis Market, by Application, 2022-2030
10.1.1. Gene & cell therapy development
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Vaccine development
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Diseases diagnosis
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Gene Synthesis Market, By End Users
11.1. Gene Synthesis Market, by End Users, 2022-2030
11.1.1. Biotechnology & pharmaceutical companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Academic & government research institutes
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Contract research organizations
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Gene Synthesis Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Method (2017-2030)
12.1.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End Users (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End Users (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End Users (2017-2030)
Chapter 13. Company Profiles
13.1. OriGene Technologies,Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Integrated DNA Technologies, Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ProMab Biotechnologies, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Eurofins Scientific
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Biomatik
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. ProteoGenix
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bosyer Biological Technology
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GenScript
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Brooks Automation, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments